SARS-CoV-2

[ACS Nano] The authors recently reported a SARS-CoV-2 human Fc-conjugated receptor-binding domain mRNA vaccine delivered via lipid nanoparticles.

[Cell Metabolism] Researchers describe the detection of SARS-CoV-2 viral antigen in pancreatic beta cells in autopsy samples from individuals with COVID-19.

[Cell Host & Microbe] Investigators review how epitopes identified throughout the SARS-CoV-2 proteome reveal significant correlation between number of epitopes defined and size of the antigen provenance.

[Nature Communications] The authors obtained serum and saliva samples from groups of vaccinated, infected and uninfected individuals and characterize the antibody response to receptor binding domain mutant strains.

[Cell] Investigators describef HIV-1 Env Fab-dimerized glycan-reactive broadly neutralizing Ab without VH-swapped domains from simian-human immunodeficiency virus-infected macaques.

[Cell Research] The authors reportedthe humoral immune response to circulating SARS-CoV-2 variants, such as 501Y.V2, of the plasma and neutralizing antibodies elicited by CoronaV, ZF2001 and natural infection.